This is the single most important evidence-based fact in the entire field of opioid use disorder treatment, and it doesn’t get enough visibility given how much it should shape decisions.

The core finding

Multiple large studies, across different populations and settings, consistently find that buprenorphine and methadone treatment are associated with roughly a 50% reduction in overdose mortality compared to no medication treatment. This is one of the largest, most consistent effect sizes in addiction medicine research.

Why this matters so much

Abstinence-only approaches — without medication — do not show this same mortality benefit in the research, even when they successfully help some people stop using. This isn’t a statement that abstinence-based approaches have no value; it’s a statement that medication specifically addresses the mortality risk in a way other approaches, on their own, don’t match in the evidence.

Why medication works this well, mechanistically

MOUD stabilizes the same receptor system that opioid use disorder has altered [link to “how opioids work in the brain”], reducing cravings and withdrawal in a controlled, monitored way — this directly reduces the cycle of tolerance loss and return-to-use that drives so much overdose mortality. overdose risk after a break tool

What this means for choosing a program

A program’s stance on medication is one of the single most important factors in evaluating it — a program that doesn’t offer or actively discourages MOUD is working against the strongest mortality evidence in the field, regardless of how good its other components might be. [MOUD indicator tool] 12-questions checklist

Addressing the common objection directly

“Isn’t this just trading one addiction for another?” — no, and here’s the full, direct answer to that question. [that article]

The bottom line

If you take away one fact from this entire site, this is the one worth remembering: medication treatment for opioid use disorder is associated with roughly halving your risk of dying from this condition, compared to not using medication. That’s not a marginal benefit — it’s one of the strongest findings in modern medicine for any chronic condition.

Medically reviewed by [pending]. Sources: NIDA, SAMHSA, multiple peer-reviewed cohort studies on MOUD and mortality (e.g., Sordo et al., BMJ 2017; subsequent replications).